drugset / Trial / NCT03686085
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
RandomizedParallel-groupDouble-blindPrevention
Summary
To investigate whether vaginal dinoprostone administered before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in nulliparous women.
Timeline
- Start
- 2018-09-30
- Primary completion
- 2019-03-01
- Completion
- 2019-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 3 mg | Other |